How to Validate a Molecular Diagnostic Test
By Dr. Zubair Khalid, DVM, MS, PhD ·
Quick Answer
- Validate a new molecular diagnostic test by running accuracy, precision, analytical sensitivity, and analytical specificity studies with predefined acceptance criteria before clinical use.
- Document every validation step in a standard operating procedure and retain raw data, operator records, and lot information for regulatory and accreditation review.
- Validation results apply only to the specific test, instruments, reagents, and sample types tested, so revalidation is required when any component changes.
At a Glance
| Validation Parameter | What It Measures | Typical Study Design | Acceptance Criterion |
|---|---|---|---|
| Accuracy | Agreement between test results and a reference method or known sample status | Test 20 to 50 known positive and negative samples in parallel with the reference method | At least 95 percent agreement with the reference method |
| Precision | Repeatability and reproducibility of results | Run the same samples multiple times on the same day and across different days, operators, or instruments | Coefficient of variation below 5 percent for quantitative tests |
| Analytical Sensitivity | The lowest amount of target that the test can reliably detect | Test serial dilutions of a known positive sample or control | Detection in at least 95 percent of replicates at the claimed limit |
| Analytical Specificity | The ability to detect only the intended target | Test samples containing closely related organisms or interfering substances | No false positives in any cross-reactivity sample |
Understanding the Validation Requirement
Molecular diagnostic tests detect nucleic acid targets such as DNA or RNA from pathogens, genetic markers, or other biological materials. These tests include polymerase chain reaction assays, isothermal amplification methods, and sequencing-based approaches. Before a laboratory uses a new test for patient samples, research samples, or animal health decisions, the test must be validated to confirm that it performs as intended.
Validation is the process of collecting evidence that a test is fit for its intended purpose. This evidence comes from structured experiments that measure how well the test detects its target, how consistently it produces the same result, and how it behaves when the target is absent or present at low levels. The U.S. Bureau of Labor Statistics describes the broader laboratory environment where such work occurs, noting that biological technicians and clinical laboratory technologists work in settings that require careful adherence to procedures and quality standards. The validation process is the practical expression of that quality requirement.
Regulatory and accreditation bodies expect validation data before a test is used for clinical decisions. The exact requirements vary by jurisdiction and by the type of test. A laboratory developed test may face different expectations than a commercially manufactured kit with regulatory clearance. The validation protocol described here provides a general framework that laboratories can adapt to their specific regulatory context.
Core Validation Parameters
Accuracy
Accuracy measures how closely the test results match the true status of the sample. The true status is established by a reference method, which may be a gold standard test, a different validated assay, or a known sample panel. Accuracy is expressed as the percentage of samples that the new test classifies correctly.
To run an accuracy study, select a panel of samples that includes known positive and known negative specimens. The sample panel should represent the range of target concentrations that the test will encounter in routine use. Run each sample with the new test and with the reference method. Compare the results and calculate the percentage of agreement.
The accuracy study should include samples that are weakly positive and strongly positive, also samples with high target concentrations. A test that performs well on strong positives but misses weak positives may fail in clinical use where target levels vary. The sample panel should also include negative samples that are similar to the positive samples in their matrix, such as blood, swab, or tissue.
Precision
Precision measures how consistently the test produces the same result when the same sample is tested multiple times. Precision has two components. Repeatability is the variation when the same operator runs the same sample on the same instrument within a short time. Reproducibility is the variation when different operators, different instruments, or different days are involved.
The precision study uses a small set of samples that are tested repeatedly. The samples should include a strong positive, a weak positive near the detection limit, and a negative. Each sample is tested multiple times within a single run and across multiple runs. The results are used to calculate the coefficient of variation, which expresses the spread of results relative to the mean.
Precision data are important because they show whether the test produces stable results. A test that gives different results for the same sample on different days is not reliable for clinical decisions. The precision study also identifies the sources of variation, such as operator technique or instrument drift, that may need to be controlled.
Analytical Sensitivity
Analytical sensitivity is the lowest amount of target that the test can reliably detect. This is also called the limit of detection. The sensitivity is determined by testing a series of dilutions of a known positive sample. Each dilution is tested in multiple replicates to determine the concentration at which the test still detects the target in a high percentage of replicates.
The limit of detection is not a single number but a range. At higher target concentrations, the test detects the target in nearly all replicates. As the concentration decreases, the detection rate falls. The limit of detection is the concentration at which the test detects the target in a defined percentage of replicates, often 95 percent.
The sensitivity study should use a sample that is representative of the clinical samples the test will encounter. A purified target in buffer may behave differently than the same target in a clinical matrix. The sensitivity should be established in the actual sample matrix whenever possible.
Analytical Specificity
Analytical specificity is the ability of the test to detect only the intended target and not other organisms or substances. The specificity study tests the test against a panel of samples that contain closely related organisms, common contaminants, or substances that might interfere with the test.
The cross-reactivity panel should include organisms that are genetically similar to the target. For example, a test for a specific virus should be tested against other viruses in the same family. The panel should also include organisms that are commonly found in the same sample type, such as normal flora or common pathogens.
The interference panel tests substances that might be present in the sample and affect the test. These can include blood, mucus, drugs, or preservatives. The test should produce the correct result when these substances are present.
Practical Validation Workflow
The validation workflow follows a structured sequence that begins with planning and ends with a validation report. Each step produces records that are needed for regulatory review.
Step 1: Define the Test Purpose and Scope
Write a clear statement of what the test is intended to detect, what sample types it will be used with, and what clinical or research decisions it will support. This statement defines the scope of the validation. A test that is intended for screening a low-prevalence population may need different validation data than a test that is intended for confirming a diagnosis in a high-prevalence population.
The purpose statement also defines the sample types that must be included in the validation. If the test will be used with both blood and swab samples, the validation must include both sample types. The validation cannot be limited to one sample type if the test will be used with others.
Step 2: Select the Reference Method
The reference method is the standard against which the new test is compared. The reference method may be a commercially available test that is already validated, a sequencing method, or a culture-based method. The reference method must be well established and its performance must be known.
The reference method should be run in parallel with the new test on the same samples. The results are compared to determine the accuracy of the new test. If the reference method is not available for all samples, the validation may use a panel of samples with known status that has been established by other means.
Step 3: Design the Validation Experiments
The validation experiments are designed to answer specific questions about the test performance. The accuracy study answers the question of how often the test gives the correct result. The precision study answers the question of how consistent the test is. The sensitivity study answers the question of how much target the test can detect. The specificity study answers the question of whether the test detects only the intended target.
Each study requires a defined number of samples and replicates. The sample sizes should be large enough to provide meaningful data. A small study with only a few samples may not detect performance problems. The sample sizes should be stated in the validation protocol before the study begins.
Step 4: Run the Validation Studies
The validation studies are run according to the protocol. The operator records the results for each sample and each replicate. The raw data are retained, including the instrument readouts, the sample identifiers, and the operator identifiers.
The validation runs should be performed under the same conditions as routine testing. The same instruments, reagents, and operators should be used. If the test will be run on multiple instruments, the validation should include all instruments.
Step 5: Analyze the Data
The data from the validation studies are analyzed to determine whether the test meets the acceptance criteria. The accuracy is calculated as the percentage of correct results. The precision is calculated as the variation across replicates. The sensitivity is determined from the dilution series. The specificity is determined from the cross-reactivity and interference panels.
The analysis should be performed by a person who is not directly involved in running the test. This reduces the risk of bias in the interpretation of the results.
Step 6: Write the Validation Report
The validation report documents the purpose of the test, the validation protocol, the data collected, the analysis, and the conclusions. The report states whether the test met the acceptance criteria and whether the test is suitable for its intended use.
The validation report is the key document that is reviewed by regulatory bodies, accreditation bodies, and laboratory management. The report must be complete and accurate. The raw data must be retained and available for review.
Records and Measurements
The validation process produces a set of records that must be retained. These records include the validation protocol, the raw data, the analysis, the validation report, and the records of the operators and instruments used.
The validation protocol is the written plan that describes the studies to be performed. The protocol is written before the validation begins and is approved by the laboratory director or quality manager. The protocol includes the acceptance criteria, the sample sizes, and the procedures for running the studies.
The raw data are the original records of the test results. The raw data include the instrument readouts, the sample identifiers, the operator identifiers, and the dates and times of the runs. The raw data are retained for a defined period, which is set by the laboratory policy or regulatory requirements.
The operator records document who performed each step of the validation. The operator records include the training records and the competency assessments for each operator. The operator records are important because they show that the validation was performed by qualified personnel.
The reagent records document the lot numbers, the expiration dates, and the storage conditions for all reagents used in the validation. The reagent records are important because they allow the laboratory to trace the results to the specific reagents that were used.
Common Failure Patterns
Validation studies can fail for several reasons. The most common failure patterns are related to the design of the study, the execution of the study, or the performance of the test itself.
Insufficient Sample Size
A validation study with too few samples may not detect performance problems. The results may appear acceptable by chance, but the test may fail when it is used with a larger number of samples. The sample size should be large enough to provide meaningful confidence in the results.
Poor Sample Selection
The validation samples must represent the range of samples that the test will encounter in practice. If the validation samples are all strong positives, the test may appear to be more accurate than it is. The validation samples should include weak positives, negatives, and samples with interfering substances.
Operator Variation
The validation results may vary between operators. If the validation is performed by a single operator, the results may not reflect the performance of the test when it is used by other operators. The validation should include multiple operators whenever possible.
Instrument Variation
The test may perform differently on different instruments. If the validation is performed on a single instrument, the results may not reflect the performance of the test on other instruments. The validation should include all instruments that will be used for testing.
The Matrix Effects
The test may perform differently in different sample matrices. A test that works well with purified samples may not work well with blood or tissue samples. The validation should be performed with the actual sample matrices that will be used in practice.
Limitations of the Validation
The validation demonstrates that the test performs as intended under the conditions of the validation study. The validation does not guarantee that the test will perform well under all conditions. The validation is limited to the samples, operators, instruments, and reagents that were used in the study.
The validation does not address the clinical utility of the test. The clinical utility is the extent to which the test improves patient outcomes or informs clinical decisions. The clinical utility is established through clinical studies, which are separate from the analytical validation.
The validation does not address the cost of the test or the time required to run the test. These factors are considered separately when the laboratory decides whether to adopt the test.
The validation is a snapshot of the test performance at a single point in time. The test performance may change over time as the reagents age, the instruments drift, or the operators change. The laboratory should monitor the test performance on an ongoing basis through quality control and proficiency testing.
Safety and Regulatory Context
The validation of a molecular diagnostic test is performed in a laboratory setting that is subject to safety and regulatory requirements. The laboratory must follow the safety procedures for handling biological samples, including the use of personal protective equipment and the proper disposal of biohazardous waste.
The regulatory requirements for the validation of a molecular diagnostic test vary by the type of test and the jurisdiction. In the United States, the Food and Drug Administration regulates the tests that are commercially manufactured and sold. The tests that are developed and performed within a single laboratory may be subject to different requirements under the Clinical Laboratory Improvement Amendments (CLIA).
The laboratory must also follow the requirements of the accreditation bodies that certify the laboratory. The accreditation bodies may have specific requirements for the validation of new tests. The laboratory should review the requirements of the relevant accreditation body before beginning the validation.
The validation of a molecular diagnostic test is a professional responsibility. The laboratory director is responsible for ensuring that the test is validated before it is used for clinical testing. The laboratory director is also responsible for ensuring that the validation records are complete and accurate.
Professional Escalation Criteria
The validation process may identify problems that require escalation to the laboratory director or the quality manager. The escalation is appropriate when the test does not meet the acceptance criteria, when the validation data are inconsistent, or when the test is not performing as expected.
The escalation is also appropriate when the validation reveals a problem with the reagents, the instruments, or the operators. The laboratory director should be informed of the problem and the steps that are being taken to address it.
The escalation is appropriate when the validation is not completed within the expected timeframe. The laboratory director should be informed of the delay and the reasons for the delay.
The escalation is appropriate when the validation results are ambiguous or when the data are not sufficient to support a conclusion. The laboratory director should be involved in the interpretation of the data and the decision about whether to proceed with the test.
Career Context for Laboratory Professionals
The validation of molecular diagnostic tests is a core skill for laboratory professionals who work in clinical, research, and public health settings. The U.S. Bureau of Labor Statistics describes the work of biological technicians and clinical laboratory technologists, noting that these professionals perform tests and analyses that support scientific and medical decisions. The validation of a molecular diagnostic test is a direct application of these skills.
The U.S. Department of Labor O*NET OnLine describes the tasks and skills of medical and clinical laboratory technologists, which include conducting chemical analyses, operating laboratory equipment, and maintaining quality control. The validation of a molecular diagnostic test requires these skills and the ability to design experiments, analyze data, and document results.
The National Institutes of Health Office of Intramural Training and Education provides career development resources for researchers and laboratory professionals. The validation of a molecular diagnostic test is a skill that is developed through training and experience. The NIH resources describe the importance of mentoring and professional development in the research career.
The American Society for Microbiology provides career resources for microbiologists, including information about professional roles and networking. The validation of a molecular diagnostic test is a skill that is relevant to the microbiology profession. The ASM resources describe the career paths and the professional development opportunities for microbiologists.
The Association of American Veterinary Medical Colleges provides career resources for veterinarians and veterinary researchers. The validation of a molecular diagnostic test is relevant to veterinary diagnostics, where the tests are used to detect pathogens in animals. The AAVMC resources describe the education and career paths for veterinary professionals.
Frequently Asked Questions
What is the difference between validation and verification?
Validation is the process of demonstrating that a test performs as intended for its specific purpose. Verification is the process of confirming that a test that has already been validated by a manufacturer performs as expected in the laboratory that will use it. A laboratory that adopts a commercially manufactured test may need to verify the test performance, while a laboratory that develops its own test must validate the test.
How many samples are needed for a validation study?
The number of samples depends on the test and the acceptance criteria. A typical accuracy study includes 20 to 50 known samples, and a precision study includes a smaller set of samples that are tested multiple times. The sample size should be large enough to provide meaningful confidence in the results. The sample size should be stated in the validation protocol before the study begins.
What is the limit of detection?
The limit of detection is the lowest amount of the target that the test can detect. The limit of detection is determined by testing a series of dilutions of a known positive sample. The limit of detection is the concentration at which the test detects the target in a defined percentage of replicates, often 95 percent.
What is the difference between analytical sensitivity and clinical sensitivity?
Analytical sensitivity is the ability of the test to detect the target at low concentrations. Clinical sensitivity is the ability of the test to detect the disease or condition in patients who have the disease. A test can have high analytical sensitivity but low clinical sensitivity if the target is not present at detectable levels in all patients with the disease.
What is the difference between analytical specificity and clinical specificity?
Analytical specificity is the ability of the test to detect only the intended target and not other related targets. Clinical specificity is the ability of the test to be negative in patients who do not have the disease. A test can have high analytical specificity but low clinical specificity if the target is present in patients who do not have the disease.
How often should a test be revalidated?
A test should be revalidated when any component of the test changes, including the reagents, the instruments, the sample types, or the operators. The test should also be revalidated when the test is moved to a new laboratory or when the test is used for a new purpose. The laboratory should also monitor the test performance on an ongoing basis through quality control and proficiency testing.
What is the role of the laboratory director in the validation?
The laboratory director is responsible for the validation of the test. The laboratory director approves the validation protocol, reviews the validation data, and decides whether the test is suitable for its intended use. The laboratory director is also responsible for ensuring that the validation records are maintained and accurate.
What are the common causes of validation failure?
The common causes of validation failure include insufficient sample size, poor sample selection, operator variation, instrument variation, and the use of the wrong sample matrix. The validation study should be designed to address these potential sources of variation. The validation data should be reviewed to identify the causes of any failure and to determine whether the test can be modified to improve its performance.
Using the Evidence
| Source | Best use in this topic | Important limitation |
|---|---|---|
| Occupational Outlook Handbook | official guidance | Check the linked page for current local requirements |
| O*NET OnLine | official guidance | Check the linked page for current local requirements |
| Office of Intramural Training and Education | official guidance | Check the linked page for current local requirements |
Related Articles
- Veterinary Diagnostic Laboratory Careers: From Bench to Leadership
- Clinical Research Scientist vs. Clinical Research Associate: Which Career Is Right for You?
- Molecular Cloning Workflow: Planning Validation Into Every Step
- Core Facility Careers: Navigating Scientist and Staff Roles in Academic Research
- molecular biology
References and Further Reading
- Occupational Outlook Handbook. U.S. Bureau of Labor Statistics.
- O*NET OnLine. U.S. Department of Labor.
- Office of Intramural Training and Education. National Institutes of Health.
- Careers at NSF. U.S. National Science Foundation.
- Career Services. American Society for Microbiology.
- AAVMC Career Resources. Association of American Veterinary Medical Colleges.
- NCBI Literature Resources. National Center for Biotechnology Information.
- PubMed. National Library of Medicine.
This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.